Clinical Trial Update: Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®

View source ↗

Summary

Exploratory multi-centre trial in essential thrombocythemia patients treated with XAGRID®. Completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia

Drugs mentioned

• XAGRID®

Snippet

Sponsor: Shire | Conditions: Essential Thrombocythemia (ET) | Status: COMPLETED | Results posted: 2014-07-29